
´ëÀå³»½Ã°æ ¾ÆÆ²¶ó½º
- ÀúÀÚ(±Û)Â÷Àç¸í, Á¤±â¿í
- ÃâÆÇ»ç´ëÇÑÀÇÇмÀû
- ¹ßÇàÀÏ2006.09.01
¼¼°è¿¡¼ ÀÎÁ¤¹Þ´Â ¿°Áõ¼ºÀåÁúȯ°ú ´ëÀåÁ¾¾ç ±ÇÀ§ÀÚ
¼Òȱ⳻°ú ±³¼ö·Î, ¿°Áõ¼ºÀåÁúȯ°ú ´ëÀåÁ¾¾ç ±ÇÀ§ÀÚ·Î ¾Ë·ÁÁ®ÀÖ´Ù. ÃÖ±Ù ¿ì¸®³ª¶ó¿¡¼µµ ½Ä»ýȰ ¼±¸È¿Í À°½Ä¡¤Áï¼®½Äǰ ¼·Ãë Áõ°¡·Î ¿°Áõ¼ºÀåÁúȯ°ú ´ëÀåÁ¾¾ç ȯÀÚ°¡ °è¼Ó ´Ã°í ÀÖ´Ù. ƯÈ÷ Å©·Ðº´, ±Ë¾ç¼º´ëÀå¿°À¸·Î ¾Ë·ÁÁø ¿°Áõ¼ºÀåÁúȯÀº ¼Òȱâ°ü¿¡ ¸¸¼ºÀû ¹Ýº¹Àû ¿°Áõ°ú ±Ë¾çÀÌ ³ªÅ¸³ª´Â ³Ä¡¼º ÁúȯÀ¸·Î, °æÁ¦È°µ¿ÀÇ ÁÖ¿ªÀÎ 20~30´ë°¡ Àüü ȯÀÚÀÇ Àý¹Ý ÀÌ»óÀ» Â÷ÁöÇϰí ÀÖ¾î¼ »çȸÀû °ü½ÉÀÌ ÇÊ¿äÇÏ´Ù. Â÷Àç¸í ±³¼ö´Â ¹Ì±¹ ¹öÁö´Ï¾Æ¸ÞÀ̽¼ ¼¾ÅÍ¿¡¼ ´ëÀå Áúȯ¿¡ ´ëÇØ ¿¬¼öÇϰí, ±¹³»¿¡¼´Â ´ëÇÑÀ忬±¸ÇÐȸ, ´ëÇѼÒȱâÇÐȸ, ´ëÇѼÒȱ⳻½Ã°æÇÐȸ¿¡¼ ´Ù¼öÀÇ Çмú»ó°ú Æ÷½ºÅÍ»óÀ» ¼ö»óÇϸç ÀÓ»ó Áø·á ¹× ¿¬±¸ ¼º°ú¸¦ ÀÎÁ¤¹Þ°í ÀÖ´Ù. 20³â ³Ñ°Ô ¿°Áõ¼ºÀåÁúȯ°ú ´ëÀåÁ¾¾ç ¿¬±¸¸¦ Áö¼ÓÇÏ¸é¼ ´Ù¼öÀÇ ±¹Ã¥ ¿¬±¸¿Í ÇÐȸ ¿¬±¸ºñ¸¦ ¼ö»óÇÏ´Â ¼º°ú¸¦ º¸¿´´Ù. ÃÖ±Ù¿¡´Â ÀÇ·á ȯ°æÀÇ °³¼±À» À§ÇÏ¿© ÀÇ·á Á¤Ã¥°ú ÀÇ·á º¸Çè¿¡ ´ëÇÑ »çȸÀû Ȱµ¿µµ Áö¼ÓÇϰí ÀÖ´Ù.
Á¦ ¸ñ | ¹«Åë´ëÀå³»½Ã°æ »ðÀÔ¹ý – °ø±â¸¦ ³ÖÁö ¾Ê´Â | ||
---|---|---|---|
ÃâÆÇ»ç | ´ëÇÑÀÇÇмÀû | ¹ßÇàÀÏ | 2012 |
Á¦ ¸ñ | ¼Òȱ⳻½Ã°æ ¾ÆÆ²¶ó½º – »óºÎÀ§Àå°ü, ÇϺÎÀ§Àå°ü | ||
---|---|---|---|
ÃâÆÇ»ç | ´ëÇÑÀÇÇмÀû | ¹ßÇàÀÏ | 2011 |
Á¦ ¸ñ | Áøº¸µÈ ¼Òȱ⠳»½Ã°æ ¾ÆÆ²¶ó½º : Çö´ë¿ª ³»½Ã°æ°ú °íÈÁú ³»½Ã°æ | ||
---|---|---|---|
ÃâÆÇ»ç | ´ëÇÑÀÇÇмÀû | ¹ßÇàÀÏ | 2008 |
Á¦ ¸ñ | ¼ÒȰü Ä¡·á³»½Ã°æ ¼ú±â ¾ÆÆ²¶ó½º | ||
---|---|---|---|
ÃâÆÇ»ç | ´ëÇÑÀÇÇмÀû | ¹ßÇàÀÏ | 2005 |
Á¦ ¸ñ | ÀÏ»óÁø·á¿¡¼ ÈçÈ÷ Á¢ÇÏ´Â 100°¡Áö Àǹ®Á¡¿¡ ´ëÇÑ Q & A | ||
---|---|---|---|
ÃâÆÇ»ç | ´ëÇÑÀÇÇмÀû | ¹ßÇàÀÏ | 2006 |
Á¦ ¸ñ | ¹®Áø¿¡ ÀÇÇÑ ¼ÒȱâÁúȯÀÇ °¨º°Áø´Ü | ||
---|---|---|---|
ÃâÆÇ»ç | ´ëÇÑÀÇÇмÀû | ¹ßÇàÀÏ | 2006 |
Á¦ ¸ñ | Demographic Characteristics and Economic Burden of Clostridioides difficile Infection in Korea: A Nationwide Population-Based Study after Propensity Score Matching | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | Antibiotics |
Á¦ ¸ñ | A Machine Learning-Based Diagnostic Model for Crohn's Disease and Ulcerative Colitis Utilizing Fecal Microbiome Analysis | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | MICROORGANISMS |
Á¦ ¸ñ | Association between pre-diagnostic serum uric acid levels in patients with newly diagnosed epilepsy and conversion rate to drug-resistant epilepsy within 5 years: A common data model analysis | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | Seizure |
Á¦ ¸ñ | Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, randomized study | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | JOURNAL OF GASTROENTEROLOGY |
Á¦ ¸ñ | Personalized prediction of survival rate with combination of penalized Cox models in patients with colorectal cancer | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | Medicine (United States) |
Á¦ ¸ñ | Association between impaired glucose metabolism and long-term prognosis at the time of diagnosis of depression: Impaired glucose metabolism as a promising biomarker proposed through a machine-learning approach | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö | European Psychiatry |
Á¦ ¸ñ | Chasm between Public Perceptions and Epidemiological Data on Colorectal Cancer | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö | Gut and Liver |
´ëÀå¾Ï°ú ´ëÀå¾ÏÀÇ ¾¾¾ÑÀÎ ´ëÀå ¼±Á¾ÀÇ Áø´Ü, Ä¡·á¿¡ ´ëÇÑ Ä¡·á¹ýÀ» °³¹ßÇÏ°í ¿¬±¸Çϴµ¥ ±â¿©ÇÔ. ƯÈ÷, ´ëÀå³»½Ã°æÀÇ Áú°ü¸®¿¡ ´ëÇÑ ´Ù¼öÀÇ ¿¬±¸¸¦ ÁøÇàÇÏ¸é¼ ±¹°³ ´ëÀå³»½Ã°æÀÇ Áú°ü¸® ÁöÇ¥¸¦ °³¹ßÇϴµ¥ ±â¿©ÇÔ. ±¹°¡¾Ï°ËÁø »ç¾÷¿¡¼ ´ëÀå¾Ï °ËÁø¿¡ ´ëÇÑ ´Ù¼öÀÇ ±¹³»¿Ü ¿¬±¸¸¦ ÅëÇØ ´ëÀå¾Ï °ËÁø¿¡ ´ëÇÑ Ç¥Áذú ÁöħÀ» Á¦°øÇÔ. ¿°Áõ»óÀåÁúȯ¿¡ ´ëÇÑ ´Ù¾çÇÑ Àӻ󿬱¸¿Í ºòµ¥ÀÌÅÍ ±â¹ÝÀÇ ¿¬±¸¸¦ º´ÇàÇϰí ÀÖÀ½. ºòµ¥ÀÌÅÍ ¿¬±¸¿Í °ü·ÃÇÏ¿© ÀÇ·áµ¥ÀÌÅÍ Ç¥ÁØÈ ¹× ºòµ¥ÀÌÅÍ ±¸Ãà ¹× ¿¬°è Ȱ¿ë¿¡ ±â¿©ÇÑ ¹Ù°¡ Å.
´ëÀå³»½Ã°æ, ´ëÀåÆú¸³, ´ëÀå¾Ï¿¡ ´ëÇØ¼´Â °úÇаú ±Ù°Å¿¡ ±â¹ÝÇÏ¿© Á¤È®ÇÏ°í ºü¸¥ Áø´Ü°ú Ä¡·á¸¦ Á¦°øÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù°í »ý°¢ÇÔ. ÃÖ±Ù SNS µîÀ» ÅëÇØ ´Ù¾çÇÑ ÀÇÇÐ Á¤º¸°¡ ³¸³ÇÏ¸é¼ ÀÇ·áÁøÁ¶Â÷ Á¤È®ÇÏ°í ±Ù°Å ÀÖ´Â ÀÇÇÐÁ¤º¸¸¦ ÆÇº°Çϱ⠾î·Á¿ï Á¤µµÀÓ. °úÇÐÀûÀÌ°í ±Ù°ÅÀÖ´Â Á¤º¸¸¦ Á¦°øÇϱâ À§ÇÏ¿© ºí·Î±×µµ °³¼³ÇÏ°í ¿î¿ëÇϰí ÀÖÀ½. ¿°Áõ¼ºÀåÁúȯ ȯÀÚµéÀº ¿ÏÄ¡°¡ µÇÁö ¾Ê´Â ÁúȯÀ̱⠶§¹®¿¡, ºü¸¥ Áø´Ü°ú Ä¡·á ¿Ü¿¡µµ ¿À·§µ¿¾È Ä£±¸Ã³·³ ¹Ï°í ÀÇÁöÇÒ ¼ö ÀÖ´Â ÀÇ·áÁøÀÌ ÇÊ¿äÇÏ´Ù°í »ý°¢ÇÔ.
¿°Áõ¼ºÀåÁúȯ ȯÀÚµéÀÌ ¾ðÁ¦µçÁö ÆíÇÏ°Ô ¿¬¶ôÇÒ ¼ö ÀÖ´Â ÀÇ·áÁøÀÌ µÇ·Á°í ³ë·ÂÇϰí ÀÖÀ½. ºñ·Ï, ¿°Áõ¼ºÀåÁúȯÀº ÇöÀç ¿ÏÄ¡ÇÒ ¼ö ÀÖ´Â Ä¡·á ¹æ¹ýÀÌ ¾øÁö¸¸, ÀÇÇÐÀº °è¼Ó ¹ßÀüÇÏ°í ¾ðÁ¨°¡´Â ¿ÏÄ¡ÇÒ ¼ö ÀÖ´Â Ä¡·á¹ýÀ» °³¹ßÇÒ ¼öµµ ÀÖ´Ù°í »ý°¢ÇÔ. µû¶ó¼, ¿ÏÄ¡ÇÒ ¼ö ÀÖ´Â Ä¡·á¹ýÀÌ °³¹ßµÉ ¶§±îÁö´Â ¿ÏÄ¡ÇÒ ¼ö ÀÖ´Ù°í ±¤°íÇÏ´Â À߸øµÈ ÀÇÇÐÁ¤º¸¿¡ ÇöȤµÇÁö ¸»°í °úÇÐÀûÀÌ°í ±Ù°Å¿¡ ±â¹ÝÇÑ Ä¡·á¸¦ Áö¼ÓÇÏ´Â °ÍÀÌ Áß¿äÇÔ. ²ÙÁØÈ÷ ÁöÄ¡Áö ¾Ê°í ÀÇ·áÁø°ú ÇÔ²² µ¿ÇàÇÏ´Â °ÍÀÌ ¿°Áõ¼ºÀåÁúȯ ȯÀÚµéÀÌ ÇÒ ¼ö ÀÖ´Â ÃÖ¼±ÀÇ Ä¡·áÀÓ.
°µ¿°æÈñ´ëÇб³º´¿øÀº Àǰú, ÇÑÀǰú, Ä¡°ú´ëÇÐÀ» ¸ðµÎ º¸À¯ÇÑ º´¿øÀ¸·Î, 3°³ ´ëÇк´¿øÀÇ ¼öÁØ ³ôÀº ÀǷἺñ½º¸¦ ÇÑ ¹ø¿¡ ¹ÞÀ» ¼ö ÀÖ´Ù. ¿¬¸éÀû 24,000¿© Æò º»°ü Áö»ó 14Ãþ, º°°ü Áö»ó 4ÃþÀÇ 800º´»óÀ» °®Ãè´Ù. ³úÁúȯ¡¤°üÀý¡¤Ã´Ãß µî Áúȯ Áß½ÉÀ¸·Î Æ¯ÈµÈ ÇùÁø ÀÇ·á
¼ºñ½º¸¦ Á¦°øÇÏ´Â ÀÇ¡¤ÇÑ ÇùÁø¼¾ÅÍ, ȯÀÚ ¼¼°è ÃÖ°í ¼öÁØÀÇ Áø·á½Ã½ºÅÛÀ» °®Ãá Àǰú
´ëÇк´¿ø, ÇÑÀÇÇÐÀ» ¼±µµÇÏ´Â ÇÑ¹æ ºê·£µåÆÄÀ§ 1À§ ÇÑÀǰú´ëÇк´¿ø¿Í Àü¹®¼º°ú ÆíÀǼºÀ» °®Ãá ȯÀÚ¸¸Á· º´¿øÀÎ Ä¡°ú´ëÇк´¿øÀÌ ÃÖ»óÀÇ ÀǷἺñ½º¸¦ Á¦°øÇϰí ÀÖ´Ù.
¼¿ïƯº°½Ã °µ¿±¸ µ¿³²·Î 892